Evidence map›Paper›PMID 38899611›Full record

ArticleAutophagy2024

RCHY1 and OPTN: an E3-ligase and an autophagy receptor required for melanophagy, respectively.

Ki Won Lee, Yong-Yeon Cho, Kwang Dong Kim

Abstract read
In one paragraph

Article in Autophagy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ki Won LeeABC-RLRC, Gyeongsang National University, Jinju, South Korea.
Yong-Yeon ChoCollege of Pharmacy, The Catholic University of Korea, Bucheon-si, Gyeonggi-Do, Korea.
Kwang Dong KimABC-RLRC, Gyeongsang National University, Jinju, South Korea.ORCID 0000-0002-5199-3415

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysregulation of melanin homeostasis is implicated in causing skin pigmentation disorders, such as melasma due to hyperpigmentation and vitiligo due to hypopigmentation. Although the synthesis of melanin has been well studied, the removal of the formed skin pigment requires more research. We determined that β-mangostin, a plant-derived metabolite, induces the degradation of already-formed melanin in the mouse B16F10 cell line. The whitening effect of β-mangostin is mediated by macroautophagy/autophagy, as it was abolished by the knockdown of ATG5 or RB1CC1/FIP200, and by treatment with 3-methyladenine, a phosphatidylinositol 3-kinase complex inhibitor. However, the exact autophagy mechanism of melanosome degradation remains unknown. Selective autophagy for a specific cellular organelle requires specific E3-ligases and autophagic receptors for the target organelle. In this study, an E3-ligase, RCHY1, and an autophagy receptor, OPTN (optineurin), were identified as being essential for melanophagy in the β-mangostin-treated B16F10 cell line. As per our knowledge, this is the first report of a specific mechanism for the degradation of melanosomes, the target organelle of melanophagy. These findings are expected to broaden the scope of melanin homeostasis research and can be exploited for the development of therapeutics for skin pigmentation disorders.

Indexed as

AutophagyMelaninsUbiquitin-Protein LigasesAnimalsCell Cycle ProteinsCell Line, TumorHumansMacroautophagyMelanosomesMembrane Transport ProteinsMiceXanthonesCell Cycle ProteinsMelaninsMembrane Transport ProteinsOptn protein, mouseUbiquitin-Protein LigasesXanthonesMelanin homeostasismelanophagymelanosomeoptineurinRCHY1β-mangostin

Identifiers

PMID38899611
PMCPMC11423654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.